Oric Pharmaceuticals (ORIC) Shares Issued (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Shares Issued came in at $9.4 million in Q1 2026, up 35.58% YoY from $7.0 million in Q1 2025, and down 32.07% on a QoQ basis from $13.9 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Shares Issued (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Shares Issued data on file, last reported at $9.4 million in Q1 2026.
- Quarterly Shares Issued rose 35.58% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 35.58% YoY) and the FY2025 annual result came in at $13.9 million, up 23.58% from the prior year.
- Shares Issued declined to $9.4 million in Q1 2026, from $13.9 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $14.2 million in Q2 2025 to a low of $1.7 million in Q3 2022.
- A 5-year average of $7.8 million and a median of $8.7 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued plunged 68.26% — and 2024, when it soared 516.04%.
- Tracing ORIC's Shares Issued over 5 years: stood at $6.7 million in 2022, then jumped by 30.27% to $8.7 million in 2023, then gained by 29.07% to $11.2 million in 2024, then climbed by 23.58% to $13.9 million in 2025, then plunged by 32.07% to $9.4 million in 2026.
- The last three Shares Issued figures came in at $9.4 million (Q1 2026), $13.9 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.15 Mn |
| Jun 30, 2026 | 17.15 Mn |
| Mar 31, 2026 | 9.44 Mn |
| Mar 31, 2026 | 9.44 Mn |
| Dec 31, 2025 | 13.90 Mn |
| Dec 31, 2025 | 13.90 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 14.25 Mn |
| Jun 30, 2025 | 14.25 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | 11.25 Mn |
| Dec 31, 2024 | 11.25 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 10.95 Mn |
| Jun 30, 2024 | 10.95 Mn |
| Mar 31, 2024 | 10.82 Mn |
| Mar 31, 2024 | 10.82 Mn |